Innate immunity activation involved in unprotected porcine auto-transplant kidneys preserved by naked caspase-3 siRNA - Wikidata - awgldk - TriplyDB

Innate immunity activation involved in unprotected porcine auto-transplant kidneys preserved by naked caspase-3 siRNA

Innate immunity activation involved in unprotected porcine auto-transplant kidneys preserved by naked caspase-3 siRNA

http://www.wikidata.org/entity/Q37357423

about

Fighting against kidney diseases with small interfering RNA: opportunities and challenges Emerging therapies targeting intra-organ inflammation in transplantation Rapamycin protects kidney against ischemia reperfusion injury through recruitment of NKT cells.A normative study of the synovial fluid proteome from healthy porcine knee joints.Immunotherapy of hepatocellular carcinoma with small double-stranded RNA.Cyclic helix B peptide inhibits ischemia reperfusion-induced renal fibrosis via the PI3K/Akt/FoxO3a pathway.A novel cyclic helix B peptide inhibits dendritic cell maturation during amelioration of acute kidney graft rejection through Jak-2/STAT3/SOCS1.The Protective Effects of Helix B Surface Peptide on Experimental Acute Liver Injury Induced by Carbon Tetrachloride.

P2860

Q27010574-0D61D01D-04E4-4F5E-9B03-6C45B7E5531E Q28085496-698286C6-67AE-4CF6-AE42-36F24B6C4DE1 Q34091448-E8B24C5A-732C-42AE-A634-568B04C40FCA Q34286058-7CDDD43F-DF42-470B-AD36-A40DFB8E17A0 Q35179465-BAC74106-9645-4BC4-ABDF-CE3B2AEBEAC5 Q36270392-F6683CB8-8CB8-4240-9BD1-AEDA936DE178 Q36349980-43E89383-3B11-4973-9D17-7B0C7DC26C27 Q38709407-4A078E18-3F11-4D8B-9E1C-D29FE4EDD39D

P2860

Innate immunity activation involved in unprotected porcine auto-transplant kidneys preserved by naked caspase-3 siRNA

http://www.wikidata.org/entity/Q37357423

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Innate immunity activation inv ...... erved by naked caspase-3 siRNA

@en

Innate immunity activation inv ...... rved by naked caspase-3 siRNA.

@nl

type

label

Innate immunity activation inv ...... erved by naked caspase-3 siRNA

@en

Innate immunity activation inv ...... rved by naked caspase-3 siRNA.

@nl

prefLabel

Innate immunity activation inv ...... erved by naked caspase-3 siRNA

@en

Innate immunity activation inv ...... rved by naked caspase-3 siRNA.

@nl

P1433

Q37357423-2F53F49D-D123-4062-B5EA-AD992F57E186

P1476

Q37357423-A61DFA90-2878-4CA2-8AEA-27BEB55143CA

P2093

Q37357423-1C45AD2A-FBD6-4CBE-ADCD-607DB53CCB65

Q37357423-29C2C22E-36D2-4AAC-8F3C-3497E53AC41B

Q37357423-337F3278-56F1-4324-9631-CEC71C9BF0ED

Q37357423-34B54E8E-E8AD-4279-865A-681A3EE78D2E

Q37357423-51EB5D99-EA21-44BA-83E2-9B4874A41C01

Q37357423-52412D14-2058-428A-BB7A-CAD807E11313

Q37357423-78302F30-991F-4E14-A252-6D2FBBB18A17

Q37357423-B6CE4322-7ECA-4891-8D83-B2DB0E9A9C76

Q37357423-BC167CC1-C855-4697-B304-579DA74FE877

Q37357423-C2ADE88B-454A-48FE-9BAB-0A83365D43D3

P2860

Q37357423-02E3CE75-5163-4482-AB63-9388C1B88E89

Q37357423-1339B4A6-00D4-465B-AFB3-04F125A36171

Q37357423-133D1833-9DCA-4A37-B3B2-4D13EBD5470D

Q37357423-183D5168-6738-4825-8E91-E240EE67539F

Q37357423-1A5A31CB-26EF-4E28-9C8C-6E156D18FDB2

Q37357423-20E32B67-E483-460A-B07F-D886C614166A

Q37357423-57BD6315-EF3D-4DE9-8F56-702F81793FD8

Q37357423-5CC590D7-3AC3-4D88-9F2F-0C4DFFA951B0

Q37357423-65F4E9BD-0539-49FE-A0C5-342873364B2D

Q37357423-66B10503-435C-4527-B213-224C0BFD019C

P2888

Q37357423-1D29CC18-6252-48D4-9EF3-750D0A390347

P304

Q37357423-2FC695B7-B322-448F-8808-82B9F2CA3A08

P31

Q37357423-453935AC-73B0-4A1A-9579-C6A56361F018

P356

Q37357423-EB4F423A-CE1E-4C6D-87B0-BDB1E621DDA3

P478

Q37357423-B2FA1B05-78A0-4342-8480-90609CED5694

P577

Q37357423-BEC22AB6-6A0E-4C14-9C55-795CBF099488

P5875

Q37357423-80943E01-9814-47E3-BB5E-5D66AB719B09

P6179

Q37357423-FD5CDF63-B0F0-4221-8604-68F688494885

P698

Q37357423-FF11BD8B-FBAE-49AA-B384-3D190CD9B88A

P932

Q37357423-81627C88-C06C-48F8-9D91-32F8CB46F6E2

P356

1479-5876-11-210

P1433

Journal of Translational Medicine

P1476

Innate immunity activation inv ...... erved by naked caspase-3 siRNA

@en

P2093

Bin Yang

http://www.w3.org/2001/XMLSchema#string

Cheng Yang

http://www.w3.org/2001/XMLSchema#string

Long Li

http://www.w3.org/2001/XMLSchema#string

Michael L Nicholson

http://www.w3.org/2001/XMLSchema#string

Ming Xu

http://www.w3.org/2001/XMLSchema#string

Ruiming Rong

http://www.w3.org/2001/XMLSchema#string

Tian Zhao

http://www.w3.org/2001/XMLSchema#string

Tongyu Zhu

http://www.w3.org/2001/XMLSchema#string

Yichen Jia

http://www.w3.org/2001/XMLSchema#string

Yinjia Xue

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

Toll-like receptors: key players in antiviral immunity

HMGB1 and RAGE in inflammation and cancer

Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition.

TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren's syndrome patients.

High mobility group [corrected] box 1 mediates neutrophil recruitment in myocardial ischemia-reperfusion injury through toll like receptor 4-related pathway.

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury.

Promiscuous 8-alkoxyadenosines in the guide strand of an siRNA: modulation of silencing efficacy and off-pathway protein binding.

Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis

P2888

1479-5876-11-210

P304

210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-11-210

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256608770

http://www.w3.org/2001/XMLSchema#string

P6179

1047800126

http://www.w3.org/2001/XMLSchema#string

P698

24034868

http://www.w3.org/2001/XMLSchema#string

P932

3847504

http://www.w3.org/2001/XMLSchema#string